Signals from these complex points of care and payments show up in real-world data, and these signals have predictive value. Seeing them, and understanding them, is an advantage.

Nationally-representative health care claims & EMR data product:
Analyze drug, medical device, diagnostics and facilities companies quickly and accurately.

 Transaction-level data:
Develop multiple KPIs and drive granular insights into product revenue and disease dynamics.

 Data enriched for investor needs:
Enhance speed to insight and access to institutional investors with dozens of external data sources cleansed and enriched with tagging (product, provider, disease, and ticker).

Kyber Data Science was created for investors by investors. Our founding team
recognized the blind spots in investment data science tools, and also how they
could leverage pharma teams’ transactional alt-data for investor insights.

Now, they’ve recruited a team of health care data science experts to create an
advantage for Forian clients: a suite of well-curated health care data offerings
for financial services.